| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773846 | Kidney International Reports | 2018 | 6 Pages |
Abstract
In patients with aPLA2R-associated PMN, reduction in circulating aPLA2R precedes clinical remission. Persistence of aPLA2R at the end of therapy is associated with clinical resistance.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
R. Ramachandran, A.K. Yadav, V. Kumar, N. Inamdar, R. Nada, K.L. Gupta, V. Jha,